



Predominance of Central Asian strain (ST 26) in Mycobacterium tuberculosis 
isolates from Balochistan by spoligotyping 
 
Muhammad Shafee1, Ferhat Abbas1, Zunera Tanveer2, Andrew Whitelaw3, Lemese Ah Tow4, 
Muhammad Ashraf5, Irshad Ahmad6,7, Simon G Patching6, Abdul Jabbar8, Ali Akbar9, Mohammad Zahid 
Mustafa1 
 
1 Centre for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, 
Pakistan 
2 Department of Physiology, Bloan University of Medical and Health Sciences, Quetta, Pakistan 
3 Division of Medical Microbiology, University of Stellenbosch, Cape Town, South Africa 
4 Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, 
Cape Town, South Africa 
5 Fatima Jinnah Chest and General Hospital, Quetta, Pakistan 
6 School of Biomedical Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, 
United Kingdom 
7 Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan 
8 Department of Medical Lab Technology, University of Haripur, Haripur, Pakistan 
9 Department of Microbiology, Faculty of Life Sciences, University of Balochistan, Quetta, Pakistan 
 
Abstract 
Introduction: Tuberculosis is a chronic debilitating infectious disease causing a severe challenge to public health, especially in developing 
countries. The aim of this study was to examine genetic diversity in Mycobacterium tuberculosis strains circulating in the Balochistan region 
of Pakistan. 
Methodology: One hundred isolates collected from patients visiting the Fatima Jinnah TB Hospital in Quetta were subjected to genotype 
analysis by spoligotyping. 
Results: Three main genotypes were identified: Central Asian Strain 1 (CAS1) (n = 89), East African Indian (EAI) strain (n = 7) and Latin 
American Mediterranean (LAM) strain (n = 3). The CAS1 clade (ST 26) had high genetic diversity represented by seven different 
spoligopatterns, of which one had major predominace (n = 75). 
Conclusions: This is the first insight into the genotype of M. tuberculosis strains in the Balochistan region that might serve as a base line study 
for control of tuberculosis in the community. 
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Introduction 
Tuberculosis remains a major health concern 
throughout the world, especially in developing 
countries. This is despite effective treatments, 
diagnostic and preventive measures that have become 
available in the last few decades. Molecular based 
typing techniques for the causative Mycobacterium 
tuberculosis (M. tuberculosis) complex have emerged 
as effective tools based on variation in insertion 
sequences and repetitive genomic sequences [1-3]. M. 
tuberculosis has a highly conserved genome containing 
useful markers that can be exploited in different typing 
techniques, such as those using Insertion Sequence 
IS6110 [4], Mycobacterial Interspersed Repetitive 
Units-Variable Number of Tandem Repeats (MIRU-
VNTR) [5], Large Sequence Polymorphism (LSP) [6], 
Restriction Fragment Length Polymorphism (RFLP) 
[7] and reverse line dot blot spoligotyping [8,9]. 
Based on sequencing of M. tuberculosis strain 
H37Rv, the complete genome contains 4,411,539 base 
pairs with densely packed coding regions. It comprises 
approximately 4,000 protein coding regions and has a 
very high guanine and cytosine content of 65.6%. 
Comparative genome sequencing of M. tuberculosis 
strains revealed that they have an overall genomic 
similarity of 99.9% [10]. The genome is is rich in 
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repetitive DNA with two types of repeat sequences, 
interspersed repeats and tandem repeats. Interspersed 
repeats include insertion sequences (IS), which are 
small mobile genetic elements of less than 2.5 kb in 
size, and direct repeats (DRs), which are 36-bp 
sequences in the chromosomal region interspersed by 
unique 35 to 41 bp spacer DNA sequences. DRs are 
members of the universal Clustered Regularly 
Interspersed Palindromic Repeats (CRISPR) DNA 
sequence family also present in the M. tuberculosis 
complex with poorly known physiological activity [11]. 
Tandem repeats are arrays of consecutive base pair 
repeats in the noncoding region of M. tuberculosis 
DNA. 
Spoligotyping (or spacer oligonucleotide typing) is 
a PCR-based reverse hybridization technique widely 
used for strain typing of M. tuberculosis [8,9]. It is 
based on polymorphism in the DR region of M. 
tuberculosis strains, where it identifies the presence or 
absence of 43 spacer DNA sequences between the 
variable DRs. PCR amplification of the DR locus uses 
primers, one of which is marked with biotin. PCR 
products are hybridized perpendicularly to a membrane 
containing 43 oligonucleotides of known sequence. The 
membrane is incubated with streptavidine-peroxydase 
conjugate, which links to biotin on the PCR products, 
then hybridization signals are detected by a 
chemiluminiscence system. The order of spaces in the 
DR regions of different strains and isolates can then be 
compared. Spoligotyping is a robust, rapid, highly 
sensitive, specific and cost-effective technique 
alternative to traditional IS6110 genotyping. It is a 
valuable tool for epidemiological studies and for 
investigating genetic diversity of M. tuberculosis 
isolates. 
Tuberculosis cases have highest prevalence in 
developing countries, especially those in Asia. Indeed, 
the countries of China, India, Bangladesh, Indonesia 
and Pakistan collectively contribute 50% of the global 
burden [12], with Pakistan standing at fifth position 
[13]. The population of Pakistan, which is 
approximately 193 million people, has a tuberculosis 
incidence rate of 268 per 100,000 with an estimated 
510,000 new cases emerging each year (World Health 
Organization, 2017) [13]. The emergence and spread of 
multidrug-resistant tuberculosis in Pakistan, 
approximately 15,000 cases per year, presents a further 
critical challenge [14-17]. There are limited studies on 
the molecular epidemiology of tuberculosis in Pakistan. 
Using spoligotyping to test isolates from all over the 
country, Hasan et al. [18] reported 22 different types of 
genogroups with 39% Central Asian Strains (CAS) and 
6% Beijing strains. A study of 926 M. tuberculosis 
isolates from all over the country identified the 
predominant genotypes as Central Asian Strains 
(including CAS1, CAS sub-families and Orphan Pak 
clusters), East African-Indian (EAI) strains (4%), 
Beijing strains (3%), poorly defined TB strains (2%), 
2% Haarlem and LAM (2%) [19]. Interestingly, the 
prevalence of CAS1 was significantly higher in Punjab 
than in Sindh, North West Frontier Province and the 
Balochistan province. Also, multidrug resistance was 
significantly associated with the Beijing strains and not 
with the CAS strains [19]. A study of 1,004 pulmonary 
tuberculosis patients in Karachi identified the most 
prevalent genotype as CAS (55.6%), followed by East 
African Indian (EAI) (9.6%), T clade (4.9%), Haarlem 
(3.1%), Beijing (2.7%), U clade (2.5%), MANU (0.2%) 
and Lam American Mediterranean (LAM) (0.4%). 
Multidrug resistance was significantly associated with 
the Haarlem genotype [20]. MIRU-VNTR typing of M. 
tuberculosis isolates from Pakistan revealed that they 
were comprised of 113 CAS lineages and 87 non-CAS 
lineages [21]. A recent study of multidrug-resistant M. 
tuberculosis isolates (n = 127) from the Punjab region 
identified three main clades of CAS1_DELHI (n = 53, 
41.7%), T1 (n = 14, 11.0%) and Beijing (n = 10, 7.8%) 
strains [22]. 
Despite global and regional efforts to combat the 
disease, tuberculosis still poses a great threat at the 
international, national and regional level. Balochistan is 
the largest province of Pakistan comprising of 44% of 
the land with a scattered population. The large majority 
of people in Balochistan live in rural areas that have 
poor access to health care facilities. A large proportion 
of the provincial population is also poorly educated and 
poverty prevails throughout the province. This study 
was designed to explore genetic diversity in M. 




This study was conducted at the Fatima Jinnah TB 
Hospital in the city of Quetta (Balochistan, Pakistan). 
Sputum samples were routinely collected from patients 
visiting the hospital from all remote areas of the 
province. The study was approved by the Ethics 
Committee of the Fatima Jinnah TB Hospital and all 
patients provided written informed consent in 
accordance with the Declaration of Helsinki. 
 
Sample collection and preparation 
At the Fatima Jinnah TB Hospital, sputum samples 
were routinely tested for presence of the tuberculosis 
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bacterium by smear microscopy with Ziehl-Neelsen 
staining [23,24]. A total of 100 tuberculosis-infected 
sputum samples were randomly selected from the 
hospital laboratory. Epidemiological information for 
the 100 patients from which clinical samples were used 
is given in Table 1. Cultures were isolated from the 
samples by growth on Lowenstein-Jensen media in 
order to have colonies for strain typing. All of the 
isolates were aseptically collected and mixed with 
distilled water (700 µL). The isolates were then heat-
killed at 80 °C for 60 minutes and shipped to the 
Division of Medical Microbiology at the University of 
Cape Town, South Africa following International Air 
Transport Association (IATA) shipment rules. 
 
Genomic DNA extraction 
DNA was extracted from heat-killed bacterial 
cultures using a previously established cetyl 
trimethylammonium bromide (CTAB) method [25]. 
Briefly, after thawing the samples at 60 °C in a thermo 
mixer, 10% SDS (70 µL) and proteinase K (50 µL) were 
added, mixed and incubated at 60 °C for 1 hour. Then 5 
M NaCl (100 µL) and CTAB (10% final concentration) 
were added to each tube followed by incubation at 60 
°C for 15 minutes. The tubes were held at -70 °C for 15 
minutes followed by thawing at 60 °C for 15 minutes. 
After cooling, 24:1 chloroform/isoamyl alcohol (700 
µL) was added followed by centrifugation (12,000 rpm, 
10 minutes). The supernatant was then aspirated and 
transferred into a new tube. Cold isopropanol (700 µL) 
was added to the tube and incubated at -20 °C for 30 
minutes followed by centrifugation (12,000 rpm, 10 
minutes). The supernatant was then discarded and the 
DNA pellet was dried with 70% ethanol and 
resuspended in molecular grade water (100 µL). 
 
DNA quantification and spoligotyping 
All samples were subjected to quantification of 
genomic DNA and evaluation of protein and RNA 
impurities using a µLITE instrument (Biodrop, UK) 
following the manufacturer’s instructions. PCR 
reaction mixtures (25 µL) were prepared using specific 
biotinylated primer pairs (DRa-F 5ʹ-
GGTTTTGGGTCTGACGAC-3ʹ and DRb-R 5ʹ-
CCGAGAGGGGACGGAAAC-3) as described 
previously [25]. PCR amplification was performed over 
35 cycles with initial denaturation at 96 °C for 3 
minutes, denaturation at 96 °C for 60 seconds, 
annealing at 55 °C for 60 seconds and extension at 72 
°C for 30 seconds. The final extension was carried out 
at 72 °C for 5 minutes and the banding pattern was 
confirmed by running the product on a 2% agarose gel. 
For hybridization of the membrane, four different 
solutions were prepared from the stock solution: 250 
mL of 2X SSPE/0.1% SDS and 250 mL of 2X SSPE 
kept at 60 °C; 250 mL of 2X SSPE/0.5% SDS and 250 
mL of 2X SSPE kept at 42 °C. Spoligotyping based on 
the presence or absence of any of 43 spacers in the 
direct repeat region in the M. tuberculosis genome was 
carried out using a spogliotyping kit from Ocimum 
Biosolutions (India) following the manufacturer’s 
instructions. The membrane was then placed in 
developer for 2 minutes and in fixer for 1 minute 
followed by rinsing with water. The black spots/blocks 
identified the presence or absence of any spacer. 
The spoligotyping banding pattern was converted to 
the octal format using a two-stage process. First, the 43-
digit binary codes were divided into 14 sets of three 
digits plus the last additional remaining digit. Secondly, 
each three-digit binary set was converted to its octal 
equivalent code. Genotypes were assigned using the 
MIRU-VNTRplus web tool (https://www.miru-
vntrplus.org/MIRU/index.faces) [26,27]. A dendogram 




Out of 100 isolates, CAS was the predominant clade 
(n = 89), represented by a CAS1 Delhi (ST 26) 
spoligopattern (octal format 703777740003771) 
characterized by deletion of spacers 4-7 and 23-34 in 
the large majority of cases (n = 75). Fourteen other 
Table 1. Epidemiological information for patients from which clinical samples were used. 





20-40 years 30 
41-60 years 55 
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isolates with six unique spoligopatterns (octal format 
703347740003661, 103347740003671, 
703357740003771, 103767740003771, 
103347740003661, 703767740003671) were also 
found that matched best with the ST 26 strain genotype 
according to addition or deletion of spacers (Table 2 and 
Figure 1). 
East African Indian (EAI) was the second most 
predominant clade with octal formats 
777377777577771 (n = 4) and 777777777413771 (n = 
3), accounting for seven isolates with the ST 236 
genotype. Three isolates were best matched with a Latin 
American Mediterranean strain LAM3 with octal 
format 774177407771771 (ST 33). A single isolate was 
best matched with the T1 family having octal format 
777377757760771 (ST 53) (Table 2 and Figure 1). 
 
Discussion 
Tuberculosis is a major infectious disease that leads 
to serious health effects and is prevalent in many parts 
of the world. It is the ninth leading cause of death 
worldwide and the leading cause from a single 
infectious agent, now ranking above HIV/AIDS. In this 
respect, Pakistan is included in the top five list of high 
burden countries [13]. The various techniques used for 
genotyping of Mycobacterium strains include 
spoligotyping, for which different spoligopatterns have 
been reported in different countries [21]. Seven distinct 
lineages of M. tuberculosis strains predominate in 
various parts of the world. The lineages are Indo-
Oceanic, East Asian (including “Beijing”), Central 
Asian (CAS)/Delhi, Euro-American (including Latin 
American-Mediterranean, Haarlem, X type and T 
families), West African 1, West African 2, respectively, 
and lineage 7 in Ethiopia [28,29]. 
Our study evaluated M. tuberculosis genotypes in 
100 clinical isolates from the Balochistan region of 
Pakistan using reverse line dot blot spoligotyping. The 
main genotypes identified were CAS, EAI, LAM and 
T1, for which the CAS family accounted for 89% of 
spoligopatterns, followed by EAI (n = 7), LAM (n = 3) 
and T1 (n = 1) (Table 2). In a previous study from 
Karachi, Pakistan 445 isolates were reported as CAS1 
(ST 126) [19]. Indeed, our findings corroborate a 
number of previous studies from Karachi, which 
identified CAS1 in 41% [18], 44% [19] and 66% [30] 
and of isolates. In our study, a spoligopattern for CAS1 
(ST 26) characterized by deletion of spacers 4-7 and 23-
34 was predominant (n = 75). This spoligopattern was 
found in other studies from Karachi, which reported 
prevalences of 39% [18] and 40% [30]. A 
predominance of CAS1 has also been reported from 
Punjab [19,21,31], which is the largest province in 
Pakistan and shares a border with India. CAS1 does 
circulate in India as reported in Delhi [32] and Mumbai 
[33,34], so there is likely to be transmission of CAS1 
across the border. It is evident from our study and from 
other studies that the CAS family is the most common 
circulating genotype of M. tuberculosis in the 
Balochistan region and in Pakistan as a whole. 
The Balochistan region of Pakistan shares borders 
with Afghanistan and with Iran and there is easy and 
frequent movement of people across the country 
borders. The high circulation of CAS1 in Balochistan 
might be due to the fact that Afghanistan and Iran both 
have high levels in their populations. Frequent influx 
from Afghanistan and Iran may contribute to 
transmission and distribution of the CAS1 genotype in 
the Balochistan region [35]. It is noteworthy that the 
CAS1 genotype is predominantly limited to Middle 
Asian countries [36]. 
Table 2. Spoligopatterns for M. tuberculosis isolates from Balochistan, Pakistan. 






1 ■■■□□□□■■■■■■■■■■■■■■■□□□□□□□□□□□□■■■■■■■■■ 703777740003771 CAS1 Delhi 26 75 
2 □□■□□□□■■□■■■□□■■■■■■■□□□□□□□□□□□□■■■■□■■□■ 703347740003661 CAS 1 Delhi 26 3 
3 □□■□□□□■■□■■■□□■■■■■■■□□□□□□□□□□□□■■■■□■■■■ 103347740003671 CAS 1 Delhi 26 2 
4 ■■■□□□□■■□■■■□■■■■■■■■□□□□□□□□□□□□■■■■■■■■■ 703357740003771 CAS 1 Delhi 26 1 
5 □□■□□□□■■■■■■■□■■■■■■■□□□□□□□□□□□□■■■■■■■■■ 103767740003771 CAS 1 Delhi 26 3 
6 □□■□□□□■■□■■■□□■■■■■■■□□□□□□□□□□□□■■■■□■■□■ 103347740003661 CAS 26 1 
7 ■■■□□□□■■■■■■■□■■■■■■■□□□□□□□□□□□□■■■■□■■■■ 703767740003671 CAS1 Delhi 26 4 
8 ■■■■■■■□□□□■■■■■■■■□□□□□■■■■■■■■■□□■■■■■■■■ 774177407771771 LAM3 33 3 
9 ■■■■■■■■■□■■■■■■■■■■■■□■■■■■■■■■□□□□■■■■■■■ 777377757760771 T1 53 1 
10 ■■■■■■■■■□■■■■■■■■■■■■■■■■■■□■■■■■■■■■■■■■■ 777377777577771 EAI 5 236 4 
11 ■□□■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 777777777413771 EAI 5 236 3 
 Total isolates 100 
■ = presence of spacer (1); □ = absence of spacer (0); ST. No = spoligotype number; Key for octal formation:  000 = 0, 001 = 1,010 = 2, 011 = 3, 100 = 4, 101 
= 5, 110 = 6, 111 = 7, 0 = 0, 1 = 1. 




Figure 1. Dendrogram of M. tuberculosis isolates from Balochistan, Pakistan. 
A dendrogram was constructed based on the Jacquard index for pairwise analysis of strains. The clustering pattern of 100 isolates is illustrated. The four 
most predominant shared spoligotypes, CAS (n = 89), EAI (n = 7), LAM (n = 3) and T1 (n = 1) were recorded. 
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EAI was the second most prevalent genotype in our 
study (7%), which has a spoligopattern characterized by 
presence of spacer 33 and absence of spacer 34. The 
EAI genotype has been isolated from all provinces of 
Pakistan [18,19,30] and has also been documented in 
the neighboring countries of Afghanistan, India, 
Bangladesh and Iran. For example, EAI was 
documented in India with prevalences of 8% from Delhi 
[32] and 17% from Mumbai [37]. A much higher 
prevalence of 80% has been recorded from southern 
India. Ancient EAI strains have also been documented 
from Bangladesh, Sri Lanka, Europe, Far East countries 
and the Indo-Pak subcontinent [38]. 
The LAM genotype (3%) was found in our study 
with a unique spoligopattern (ST 33). LAM was also 
isolated from water samples in Iran [39], suggesting 
that it might be transmitted across the border between 
the two countries. The LAM genotype is relatively rare 
in Pakistan, but a few cases have been reported from the 
Sindh province [19], which shares a border with 
Balochistan. A single isolate was identified as 
belonging to the T1 family (ST 53). 
 
Conclusion 
The results of our study reflect high prevalence and 
high genetic diversity of the M. tuberculosis CAS 
family (ST 26) in the Balochistan (city of Quetta) region 
of Pakistan, followed by EAI, LAM and T1 genotypes. 
This provides baseline information on the genetic 
diversity of M. tuberculosis in the region. Further 
research encompassing a greater population throughout 
the province should be planned for a more detailed 
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